Century Therapeutics Inc. (IPSC)
NASDAQ: IPSC
· Real-Time Price · USD
0.48
-0.03 (-5.33%)
At close: Sep 19, 2025, 3:59 PM
-5.33% (1D)
| Bid | 0.48 |
| Market Cap | 41.22M |
| Revenue (ttm) | 114.13M |
| Net Income (ttm) | -23.28M |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -1.7 |
| Forward PE | -0.4 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.52 |
| Volume | 754,006 |
| Avg. Volume (20D) | 850,761 |
| Open | 0.50 |
| Previous Close | 0.51 |
| Day's Range | 0.48 - 0.51 |
| 52-Week Range | 0.34 - 1.86 |
| Beta | 1.78 |
| Ex-Dividend Date | n/a |
About IPSC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IPSC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IPSC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCentury Therapeutics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
